Is AGYTF or ORCC a better dividend investment in 2026?

AGYTF currently yields 1818.18% with a 5% 5-year dividend growth rate. ORCC yields 9.79% with 5% growth. The better choice depends on your goal: AGYTF offers higher current income.

What is the dividend yield difference between AGYTF and ORCC?

AGYTF has a forward dividend yield of 1818.18% ($2.00/share annually). ORCC yields 9.79% ($1.32/share annually). The yield gap is 1808.39 percentage points.

Home › Compare › AGYTF vs ORCC

AGYTF vs ORCC: Dividend Comparison 2026

AGYTF yields 1818.18% · ORCC yields 9.79%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 AGYTF wins by $4103414683.82M in total portfolio value

INVESTMENT

TIME HORIZON10 years

AGYTF

● Live price

1818.18%

Share price

$0.11

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$4103414683.84M

Annual income

$3,702,796,788,756,407.00

Full AGYTF calculator →

ORCC

● Live price

9.79%

Share price

$13.48

Annual div

$1.32

5Y div CAGR

-50%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$21.4K

Annual income

$1.04

Full ORCC calculator →

Portfolio growth — AGYTF vs ORCC

📍 AGYTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	AGYTF	ORCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, AGYTF + ORCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

AGYTF pays

ORCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AGYTF

Annual income on $10K today (after 15% tax)

$154,545.45/yr

After 10yr DRIP, annual income (after tax)

$3,147,377,270,442,946.00/yr

ORCC

Annual income on $10K today (after 15% tax)

$832.34/yr

After 10yr DRIP, annual income (after tax)

$0.88/yr

At 15% tax rate, AGYTF beats the other by $3,147,377,270,442,945.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AGYTF + ORCC for your $10,000?

AGYTF: 50%ORCC: 50%

100% ORCC50/50100% AGYTF

Portfolio after 10yr

$2051707341.93M

Annual income

$1,851,398,394,378,204.00/yr

Blended yield

90.24%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

AGYTF

No analyst data

Altman Z

-5.5

Piotroski

2/9

ORCC

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$16.00

+18.7% upside vs current

Range: $16.00 — $16.00

Altman Z

0.5

Piotroski

5/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AGYTF buys

ORCC buys

Politician	Chamber	Ticker	Type	Amount	Date
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-23
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$250,001 - $500,000	2022-06-16
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-14
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$50,001 - $100,000	2022-06-13
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$50,001 - $100,000	2022-06-10
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-09
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-06-08
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$50,001 - $100,000	2022-06-03
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$15,001 - $50,000	2022-05-24
Trey Hollingsworth	🏢 House	$ORCC	▲ Buy	$100,001 - $250,000	2022-05-20

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricAGYTFORCC

Forward yield	1818.18% ✓	9.79%
Annual dividend / share	$2.00 ✓	$1.32
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0% ✓	-50%
Portfolio after 10y	$4103414683.84M ✓	$21.4K
Annual income after 10y	$3,702,796,788,756,407.00 ✓	$1.04
Total dividends collected	$4074760433.31M ✓	$1.0K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC

Year-by-year: AGYTF vs ORCC ($10,000, DRIP)

Year	AGYTF Portfolio	AGYTF Income/yr	ORCC Portfolio	ORCC Income/yr	Gap
1← crossover	$192,518	$181,818.18	$11,190	$489.61	+$181.3K → AGYTF
2	$3,477,331	$3,271,336.99	$12,229	$256.01	+$3.47M → AGYTF
3	$58,943,217	$55,222,471.89	$13,216	$130.74	+$58.93M → AGYTF
4	$937,891,469	$874,822,227.57	$14,207	$66.02	+$937.88M → AGYTF
5	$14,012,869,532	$13,009,325,660.38	$15,234	$33.17	+$14012.85M → AGYTF
6	$196,647,994,247	$181,654,223,846.76	$16,317	$16.62	+$196647.98M → AGYTF
7	$2,592,865,386,485	$2,382,452,032,641.56	$17,468	$8.32	+$2592865.37M → AGYTF
8	$32,132,661,421,271	$29,358,295,457,731.54	$18,695	$4.16	+$32132661.40M → AGYTF
9	$374,409,247,740,494	$340,027,300,019,734.44	$20,006	$2.08	+$374409247.72M → AGYTF
10	$4,103,414,683,838,736	$3,702,796,788,756,407.00	$21,407	$1.04	+$4103414683.82M → AGYTF

AGYTF vs ORCC: Complete Analysis 2026

AGYTF — Stock

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

Full AGYTF Calculator →

ORCC — BDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →

📬

Get this AGYTF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AGYTF vs SCHD AGYTF vs JEPI AGYTF vs O AGYTF vs KO AGYTF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.